Central VF progression faster in NTG with autonomic dysfunction

Article

Central visual field (VF) progression is faster in patients with normal tension glaucoma (NTG) and lower heart-rate variability than it is in NTG patients with higher heart-rate variability, according to recently published research.

Central visual field (VF) progression is faster in patients with normal tension glaucoma (NTG) and lower heart-rate variability than it is in NTG patients with higher heart-rate variability, according to research published online before print in Investigative Ophthalmology and Visual Science.

Lower heart-rate variability indicates autonomic dysfunction with sympathetic predominance, note the researchers, who add that intraocular pressure-independent risk factors such as migraine, orthostatic hypotension and autonomic dysfunction are related to central VF progression.

The Seoul, South Korea, investigators retrospectively studied 48 eyes with NTG in more than 7 VF tests during at least 5 years of follow-up. Rheumatology assessments determined their heart-rate variability.

The scientists organized patients into heart-rate-variability groups based on the standard deviation value of the qualified normal-to-normal intervals of the assessment. They divided VF into central and peripheral regions as well as superior and inferior regions. Using a linear mixed model, they examined each group’s rates of change in the mean thresholds of each designated region. They also examined potential clinical factors associated with central VF progression.

The lowest and highest heart-rate-variability groups showed similar stages of glaucoma damage, as revealed by baseline VF. The two groups also had similar mean global rate of VF changes, with only the rate of VF change in the central and superior central regions differing significantly. Significantly associated with central VF progression were baseline VF pattern standard deviation, migraine, orthostatic hypotension, and lower heart-rate-variability.

To view the abstract of the study, visit the journal's website.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.